Tekla Life Sciences Investors (HQL): Price and Financial Metrics
HQL Price/Volume Stats
| Current price | $13.50 | 52-week high | $15.90 |
| Prev. close | $13.15 | 52-week low | $12.76 |
| Day low | $13.16 | Volume | 94,400 |
| Day high | $13.54 | Avg. volume | 93,448 |
| 50-day MA | $14.47 | Dividend yield | 14.14% |
| 200-day MA | $14.33 | Market Cap | 369.24M |
HQL Stock Price Chart Interactive Chart >
Tekla Life Sciences Investors (HQL) Company Bio
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
HQL Price Returns
| 1-mo | -2.39% |
| 3-mo | -13.18% |
| 6-mo | -4.66% |
| 1-year | 0.97% |
| 3-year | -30.34% |
| 5-year | -23.86% |
| YTD | 0.30% |
| 2023 | -5.28% |
| 2022 | -26.11% |
| 2021 | -2.63% |
| 2020 | 13.31% |
| 2019 | 15.35% |
HQL Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...